Treace Medical Concepts, Inc.
A medical technology company that makes instruments and implants for foot and ankle surgery, best known for the Lapiplasty procedure that corrects bunions in all three dimensions rather than just shaving off the bump. Founder John Treace started the Florida-based company in 2014 after years at another medical-device firm, naming it after himself. Its tools treat the unstable joint at the root of the bunion, not just the cosmetic lump, and surgeons have used them on well over a hundred thousand patients.
Granted 1.18M · Bought 1.27M · Sold 5.75M
Granted 602.3K · Sold 511.2K
Granted 408.8K · Sold 476.3K
Bought 412.0K · Sold 925.0K
Granted 44.1K · Bought 150.1K · Sold 690.0K
Granted 7.9K · Sold 329.2K
Granted 1.02M · Bought 19.8K · Sold 1.0K
Granted 841.1K · Bought 3.7K · Sold 790
Granted 1.03M · Sold 275.5K
Granted 416.4K · Bought 130.0K
Granted 308.6K
Granted 150.0K
Granted 363.0K
Granted 242.2K · Bought 1.8K · Sold 733
Granted 75.2K · Bought 25.0K
Granted 74.6K · Bought 19.4K
Granted 75.2K
Granted 74.6K
Granted 74.1K
Granted 53.5K · Bought 4.0K · Sold 26.5K
Granted 3.4K · Bought 2.5K
Sold 1.73M
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Treace John T.Chief Executive Officer, Director, 10% owner · 69 transactions | — | 12.73M | 1.18M | 1.27M | 5.75M |
| Timbie Thomas EDirector · 24 transactions | — | 2.82Mas of Mar 2023 | 602.3K | — | 511.2K |
| Treace John RDirector · 8 transactions | — | 2.27Mas of May 2022 | 408.8K | — | 476.3K |
| Treace James TDirector · 73 transactions | — | 1.78Mas of Aug 2024 | — | 412.0K | 925.0K |
| Mott Richard WDirector · 32 transactions | — | 1.10Mas of May 2025 | 44.1K | 150.1K | 690.0K |
| Frias Jaime A.Chief Legal Officer · 4 transactions | — | 971.0Kas of Mar 2022 | 7.9K | — | 329.2K |
| Hair MarkChief Financial Officer · 22 transactions | — | 952.0K | 1.02M | 19.8K | 1.0K |
| Elder Scot MichaelChief Legl & Comp Off, CorpSec · 30 transactions | — | 794.9K | 841.1K | 3.7K | 790 |
| Scanlan Sean F.Chief Innovation Officer · 53 transactions | — | 704.7K | 1.03M | — | 275.5K |
| Bakewell John KDirector · 15 transactions | — | 546.4K | 416.4K | 130.0K | — |
| Ferguson Joe W.SVP, Research & Development · 2 transactions | — | 505.3Kas of Oct 2021 | 308.6K | — | — |
| Guglielmino GaetanoChief Commercial Officer · 1 transaction | — | 490.9K | 150.0K | — | — |
| Guglielmino GuyChief Commercial Officer · 4 transactions | — | 342.9K | 363.0K | — | — |
| Berutti AaronSVP, Sales · 13 transactions | — | 205.1Kas of Aug 2025 | 242.2K | 1.8K | 733 |
| Jain DeeptiDirector · 7 transactions | — | 100.2K | 75.2K | 25.0K | — |
| Kiernan Jane EDirector · 6 transactions | — | 93.9K | 74.6K | 19.4K | — |
| Hanna BetsyDirector · 6 transactions | — | 75.2K | 75.2K | — | — |
| Berry Lance ADirector · 5 transactions | — | 74.6K | 74.6K | — | — |
| Hamilton Lawrence WDirector · 5 transactions | — | 74.1K | 74.1K | — | — |
| Owens Daniel E.Chief Human Resources Officer · 26 transactions | — | 30.9Kas of Mar 2023 | 53.5K | 4.0K | 26.5K |
| Lubben Terry W.SVP, Operations · 2 transactions | — | 3.4Kas of Mar 2022 | 3.4K | 2.5K | — |
| Bays F BarryFormer Director · 46 transactions | — | 0as of Jun 2023 | — | — | 1.73M |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -8.67M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.